Proteomics for Early Detection of Non-Muscle-Invasive Bladder Cancer: Clinically Useful Urine Protein Biomarkers
Bladder cancer is the fourth most common cancer in men, and most cases are non-muscle-invasive. A high recurrence rate is a critical problem in non-muscle-invasive bladder cancer. The availability of few urine tests hinders the effective detection of superficial and small bladder tumors. Cystoscopy...
Main Authors: | Jae-Hak Ahn, Chan-Koo Kang, Eun-Mee Kim, Ah-Ram Kim, Aram Kim |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2022-03-01
|
Series: | Life |
Subjects: | |
Online Access: | https://www.mdpi.com/2075-1729/12/3/395 |
Similar Items
-
Exploration of potential biomarkers for early bladder cancer based on urine proteomics
by: Xu Zhou, et al.
Published: (2024-02-01) -
Urinary proteomics evaluation in interstitial cystitis/painful bladder syndrome: a pilot study
by: Young Ah Goo, et al.
Published: (2010-08-01) -
Comparing CxBladder to Urine Cytology as Adjunct to Cystoscopy in Surveillance of Non-muscle Invasive Bladder Cancer—A Pilot Study
by: C. A. Chai, et al.
Published: (2021-05-01) -
Proteomics Profiling of Bladder Cancer Tissues from Early to Advanced Stages Reveals NNMT and GALK1 as Biomarkers for Early Detection and Prognosis of BCa
by: Katarina Davalieva, et al.
Published: (2023-10-01) -
Clinical evaluation of urine laminin‐γ2 monomer as a potent biomarker for non‐muscle invasive bladder cancer
by: Takashi Karashima, et al.
Published: (2023-02-01)